GS

Gursewak Singh

Active Director Director DIN 10662907
DIN 10662907 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Gursewak Singh

Data last updated:

Gursewak Singh is a Director at Gursewak Healthcare Private Limited (since 2024). Gursewak Healthcare Private Limited reported revenue of ₹5.47 Cr (FY 2025).

DIN 10662907
Primary Designation Director
First Appointment 10 Jun 2024
Oldest Company Age 2 yrs
Largest company Gursewak Healthcare Private Limited · ₹5.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gursewak Healthcare Private Limited U86100PB2024PTC061797
Director10 Jun 20242024₹5.47 Cr (FY 2025)Active

Board colleagues of Gursewak Singh

NameDINCompanyDesignation
Simernjeet Kaur10662908Gursewak Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gursewak Healthcare Private Limited
Premium access

Shareholding and investment profile for Gursewak Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gursewak Singh

Gursewak Singh currently holds 1 directorship: Gursewak Healthcare Private Limited (Director, since 10 Jun 2024, revenue ₹5.47 Cr (FY 2025)).

Gursewak Singh was first appointed on 10 Jun 2024 as Director at Gursewak Healthcare Private Limited.

The current boards of Gursewak Singh's companies include Simernjeet Kaur (Gursewak Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available